TGFB1 anticorps (AA 279-390)
Aperçu rapide pour TGFB1 anticorps (AA 279-390) (ABIN7427291)
Antigène
Voir toutes TGFB1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 279-390
-
Fonction
- Monoclonal Antibody to Transforming Growth Factor Beta 1 (TGFb1)
-
Specificité
- The antibody is a mouse monoclonal antibody raised against TGFb1. It has been selected for its ability to recognize TGFb1 in immunohistochemical staining and western blotting.
-
Purification
- Protein A + Protein G affinity chromatography
-
Immunogène
- Recombinant Transforming Growth Factor Beta 1 (TGFb1) corresdonding to Ala279~Ser390 with N-terminal His Tag
-
Isotype
- IgG2b kappa
-
-
-
-
Indications d'application
- Western blottin:g: 0.5-3 μg/mL,Immunohistochemistry: 5-30 μg/mL,Immunocytochemistry: 5-30 μg/mL,Optimal working dilutions must be determined by end user.
-
Commentaires
-
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.
-
Agent conservateur
- ProClin, Sodium azide
-
Précaution d'utilisation
- This product contains ProClin and Sodium azide: POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
-
Date de péremption
- 24 months
-
-
- TGFB1 (Transforming Growth Factor, beta 1 (TGFB1))
-
Autre désignation
- TGFb1
-
Sujet
- TGF-B1, CED, DPD1, LAP, Camurati-Engelmann Disease, Latency-associated peptide
-
UniProt
- P17246
-
Pathways
- EGFR Signaling Pathway, Dopaminergic Neurogenesis, Cellular Response to Molecule of Bacterial Origin, Glycosaminoglycan Metabolic Process, Regulation of Leukocyte Mediated Immunity, Regulation of Muscle Cell Differentiation, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Production of Molecular Mediator of Immune Response, Ribonucleoside Biosynthetic Process, Skeletal Muscle Fiber Development, Regulation of Carbohydrate Metabolic Process, Protein targeting to Nucleus, Autophagy, Cancer Immune Checkpoints
Antigène
-